SVG Sprites

Press

Press Releases 04.13.2020

Letter to Presidential Candidates

Lower Drug Prices Now shared recommendations with the Presidential candidates on how to respond to the COVID-19 pandemic and ensure affordable treatments and vaccines for all.

Press Releases 04.07.2020

New reporting from the NY Times and Sludge revealed that Big Pharma and the Trump administration are working together to profit off of the coronavirus crisis.

“The explosive report in the New York Times showing that President Trump has financial ties to the company making a version of the experimental drug he is pushing raises serious ethical, moral and legal questions that need to be immediately investigated by Congress. Is Trump personally profiting from this crisis? Is he helping his buddies in the pharmaceutical industry profiteer from the pandemic? Given the all too cozy relationship that his administration has with Big Pharma, these questions need to be thoroughly investigated.”

LDPN in the News 03.26.2020

Trump’s friends in Big Pharma are poised to make a killing off coronavirus

Front Page Live – 3/26/20

A few weeks ago, Matt Colvin of Tennessee was the subject of massive national outrage. Colvin’s crime? Buying up 17,700 bottles of hand sanitizer and selling them at a massive markup on Amazon. Colvin’s actions were worthy of the outrage. But Americans should direct the bulk of anger at Big Pharma corporations and their allies in the White House. These pharma profiteers are preparing to price gauge COVID-19 patients on a massive scale.

LDPN in the News 03.26.2020

Our moral obligation to health during the COVID-19 pandemic

Religion News Service – 3/26/20

OPED by Rev. Liz Theoharris

Press Releases 03.26.2020

Statement: Senate Passes 2 Trillion Coronavirus Relief Bill, But Big Pharma’s Profiteering Remains Unchecked

WASHINGTON (March 26, 2020) – The United States Senate just passed a $2 trillion stimulus bill in response to the coronavirus crisis in the United States. The legislation includes provisions to support hospitals, small businesses and distressed companies caught in the public health and economic fallout from the pandemic.

Press Releases 03.24.2020

Trump Administration gives Gilead greenlight to profiteer on promising COVID-19 Drug

Washington, DC (March 24, 2020) – Yesterday the Trump Administration gave the drug corporation Gilead Sciences special monopoly protection on the promising COVID-19 treatment Remdesivir, giving them a green light to price gouge on a desperately needed treatment.

Press Releases 03.20.2020

Statement: Drug Corporation Price-Gouged Potential Coronavirus Treatment

WASHINGTON (March 20, 2020) – Since the start of the coronavirus COVID-19 outbreak in the U.S. the Lower Drug Prices Now Coalition has been sounding the alarm about potential Big Pharma price gouging if President Trump and Health and Human Services Secretary Azar fail to enact price control measures that ensure affordability.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles